Profil
Mohammed Afshar is the founder.
Dr. Afshar was the founder of Ariana Pharmaceuticals SA, serving as Chief Executive Officer & Director since 2003.
Dr. Afshar is also the founder of RiboTargets Ltd. Former job at The University of York as Research Fellow.
Former job at Génomic Vision SA as Member-Supervisory Board.
Education at Université de Montpellier with undergraduate, graduate, and doctorate degrees.
Tidigare kända positioner av Mohammed Afshar
| Företag | Position | Slut |
|---|---|---|
Ariana Pharmaceuticals SA
Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Provides pharmaceutical, clinical and data technology | Grundare | 2024-08-08 |
| GENOMIC VISION | Direktör/Styrelseledamot | - |
The University of York
The University of York Other Consumer ServicesConsumer Services Functions as a College/University | Teknisk/Vetenskaplig/F&U Direktör | - |
RiboTargets Ltd.
RiboTargets Ltd. Pharmaceuticals: OtherHealth Technology Pharmaceutical research company | Grundare | - |
Mohammed Afshars utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
RiboTargets Ltd.
RiboTargets Ltd. Pharmaceuticals: OtherHealth Technology Pharmaceutical research company | Health Technology |
Université de Montpellier
Université de Montpellier Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of York
The University of York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ariana Pharmaceuticals SA
Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Provides pharmaceutical, clinical and data technology | Health Technology |
Génomic Vision SA
Génomic Vision SA Medical SpecialtiesHealth Technology Develops diagnostic tools using deoxyribonucleic acid analysis | Health Technology |
















